##  [Global and the European Facilitated Regulatory Pathways](/regulatory-radio/global-and-the-european-facilitated-regulatory-pathways) 

- Subscribe:
- [Apple Podcasts](https://podcasts.apple.com/us/podcast/freyr-regulatory-radio/id1608849172)
- [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2ZyZXlyc29sdXRpb25zL2ZlZWQueG1s)
- [Spotify](https://open.spotify.com/show/4m38aNEhFY7uaCY4DcSssj?si=S4cJhnXKQn2PRiofh9D1sA&nd=1)
- [Podbean](https://freyrsolutions.podbean.com/%20)
- [Amazon Music](https://music.amazon.com/podcasts/200dc633-e32d-4718-a1f6-3f5180923c20/freyr-regulatory-radio)
- [Youtube](https://www.youtube.com/watch?v=O_R6T6E0IIs)





# Episode 5

## Global and the European Facilitated Regulatory Pathways

Time-to-market plays a major role in addressing the needs of vulnerable patient groups. Facilitated pathways across the globe accelerate the timelines of innovative drug molecules, allowing fast-tracked approval pathways for essential medicines. Our experts address the necessary requirements of innovators and elaborate on the facilitated Regulatory pathways.

***Reference Links***

- [Centre for Innovation in Regulatory Science report New drug approvals in six major authorities 2011-2020](https://cirsci.org/wp-content/uploads/dlm_uploads/2021/06/CIRS-RD-Briefing-81-6-agencies-v5.pdf)







 <a data-entity-id="3556" data-entity-op="like" data-entity-type="node" title="Like">Like</a> 7 

 <a class="disable-status" data-entity-id="3556" data-entity-op="dislike" data-entity-type="node" title="Dislike">Dislike</a> 0 

 



 0 Comments 

## Add new comment

  You must have JavaScript enabled to use this form.

 Your name  

    Comment 

 

[About text formats](/filter/tips)

#### Plain text

- No HTML tags allowed.
- Lines and paragraphs break automatically.
- Web page addresses and email addresses turn into links automatically.